Azithromycin Therapy for Prevention of Chronic Lung Disease of Prematurity (AZTEC)
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial
Lancet Respir Med 2024 Apr 25;[EPub Ahead of Print], J Lowe, D Gillespie, A Aboklaish, TMM Lau, C Consoli, M Babu, M Goddard, K Hood, N Klein, E Thomas-Jones, M Turner, M Hubbard, J Marchesi, J Berrington, S KotechaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.